Brazilian IP News - MJZanon - Page 156

Recursion secures funds to support AI-based drug discovery

Tuesday, July 16, 2019 Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding

Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation

Thursday, July 18, 2019 | Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard announced

Court upholds the validity and determined Actavis infringement of patent protecting RELISTOR tablets

Wednesday, July 17, 2019 | DrugName: methylnaltrexone bromide Bausch Health Companies Inc. and Progenics Pharmaceuticals, announced that the U.S.

GB Sciences files novel patent application for chronic pain treatments based on proprietary cannabis-derived formulations

Thursday, July 18, 2019 GB Sciences, Inc., through its subsidiary, GBS Global Biopharma, Inc., has filed a novel patent application

Compugen expands intellectual property portfolio for COM701 with new U.S. patent covering combination use with anti-PD-1 antibody

Tuesday, July 16, 2019 | DrugName : COM-701 Compugen Ltd., a clinical-stage cancer immunotherapy company and leader in predictive target

MJZanon